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Consumption of raw oysters is an exposure route for human norovirus (NoV) and hepatitis A virus (HAV). Therefore, efficient
postharvest oyster treatment technology is needed to reduce public health risks. This study evaluated the inactivation of HAV
and the NoV research surrogate, murine norovirus-1 (MNV-1), in oysters (Crassostrea virginica) by electron beam (E-beam)
irradiation. The reduction of potential infection risks was quantified for E-beam irradiation technology employed on raw oysters
at various virus contamination levels. The E-beam dose required to reduce theMNV and HAV titer by 90% (D10 value) in whole
oysters was 4.05 (standard deviations [SD],0.63) and 4.83 (SD,0.08) kGy, respectively. Microbial risk assessment suggests
that if a typical serving of 12 raw oysters was contaminated with 105 PFU, a 5-kGy treatment would achieve a 12% reduction
(from 4.49 out of 10 persons to 3.95 out of 10 persons) in NoV infection and a 16% reduction (from 9.21 out of 10 persons to 7.76
out of 10 persons) in HAV infections. If the serving size contained only 102 PFU of viruses, a 5-kGy treatment would achieve a
26% reduction (2.74 out of 10 persons to 2.03 out of 10 persons) of NoV and 91% reduction (2.1 out of 10 persons to 1.93 out of
100 persons) of HAV infection risks. This study shows that although E-beam processing cannot completely eliminate the risk of
viral illness, infection risks can be reduced.
Currently, human noroviruses (NoV) and hepatitis A virus(HAV) are considered the principal viral pathogen threats to
shellfish consumers. It is estimated that noroviruses are responsi-
ble for more than half of all reported outbreaks of gastroenteritis
(1). Although normally associated with self-limiting gastroenteri-
tis, NoV accounts for 25% of hospitalizations and 11% of deaths
from food-borne illnesses in the United States (2). According to
Scharff (3), the estimated cost of NoV illnesses to the U.S. econ-
omy is $5.8 billion per year. Due to recent vaccination campaigns
and improved hygienic standards, HAV is less common in the
United States and Europe. However, HAV remains amajor public
health threat around the world. Bivalves, such as oysters, filter
large volumes of water and bioaccumulate NoV and HAV, as well
as a variety of bacterial pathogens (4–8). The U.S. oyster produc-
tion is approximately 27 million pounds per annum, 70% of
which is consumed raw (9, 10). The prevalence of NoV contami-
nation of U.S. market oysters has been estimated to be 3.9% (4)
and greater than 70% for market oysters in the United Kingdom
(11). The precise reasons for this disparity in NoV occurrence are
presently unknown. Although there have only been two known
HAV outbreaks associated with U.S. oysters in the last 20 years, a
recent study found that approximately 4.4% of U.S. market oys-
ters tested positive for HAV (4).
A variety of bacterial pathogen intervention technologies for
oysters, such as depuration, relaying, flash pasteurization, high-
pressure processing, individual quick freezing with extended fro-
zen storage, flash freezing, and ionizing irradiation, have been
recommended (12, 13). The utility of many of these approaches
against viral pathogens in the context of reducing infection risks is
still relatively limited or unknown (14). The U.S. FDA has ap-
proved the use of ionizing radiation of up to a maximum of 5.5
kGy as a pathogen intervention strategy to control naturally oc-
curring Vibrio vulnificus in shellfish (15). Currently, only a small
percentage of the commercial oysters sold in the United States are
being processed by ionizing radiation, such as cobalt-60 (personal
communication, Food Technology Services, Inc., Mulberry, FL
[16]). Ionizing radiation can be generated using either radioactive
isotopes (cobalt-60 or cesium-137) or linear accelerators to gen-
erate electron beams (E-beam). Cobalt-60 and cesium-137 gener-
ate gamma rays (photons), while E-beam is made up of a beam of
high-energy electrons. Although the basicmechanismbywhich all
types of ionizing radiation inactivate microorganisms is thought
to be the same, i.e., DNA strand breakage, there are fundamental
differences between E-beam and gamma irradiation with respect
to energy and dose rate when used for commercial food process-
ing. For example, the energy of gamma rays in cobalt-60 is approx-
imately 1MeV, while for E-beam-associated electrons it is usually
around 10 MeV. The dose rate of gamma rays from cobalt-60 is
often in the range of hundreds of grays per minute, while in the
case of E-beam the dose rate is in the range of tens of millions of
grays per minute (17). Thus, during commercial E-beam irradia-
tion, microbial pathogens experience ionizing radiation at signif-
icantly higher dose rate (usually in seconds) conditions than
pathogens experiencing commercial cobalt-60 irradiation.
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To the best of our knowledge, there are no published reports
addressing the use of E-beam to reduce or eliminate viral patho-
gens, such as NoV and HAV, in whole oysters. Additionally, there
is no information on the reduction in viral infection risks that can
be expected when a pathogen-kill step, such as E-beam radiation,
is used for raw oysters. The aims of this studywere 2-fold. The first
aim was to determine the sensitivity of the widely used NoV sur-
rogate, murine norovirus (MNV-1), and a tissue culture-adapted
HAV strain to E-beam irradiation in whole oysters. The second
aim was to quantify the reduction in potential infection risks that
would be achievable if raw oysters contaminated with different
levels of virus were irradiated at various E-beam doses approved
by the FDA. The underlying hypothesis was that NoV andHAV in
oysters are susceptible to E-beam irradiation, and that defined
reductions in health risks are achievable with the use of E-beam
irradiation.
MATERIALS AND METHODS
Murine norovirus and hepatitis A virus. Murine norovirus (MNV-1)
was kindly provided by HerbertW. Virgin IV,Washington University, St.
Louis, MO. The virus was propagated in RAW 264.7 (ATCC, Manassas,
VA) cells cultured in Dulbecco’s minimum essential medium (DMEM)
(Mediatech, Manassas, VA) containing 10% fetal bovine serum (FBS; At-
lanta Biologicals, Atlanta, GA), 1% HEPES buffer, 1% penicillin-strepto-
mycin (Mediatech). The MNV stocks were prepared and stored as previ-
ously described (18). The HAV strain obtained from the American Type
Culture Collection (Manassas, VA) was strain VR-1402, a cell culture-
adapted cytopathic clone of strainHM-175/18f. The virus was propagated
in fetal rhesus monkey kidney (FRhK-4) cells in DMEM supplemented
with 10% fetal bovine serum (Invitrogen Corp., Carlsbad, CA). The HAV
stocks were prepared and stored as previously described (13).
Virus-contaminatedoysters andoystermeathomogenates.The sen-
sitivity of the two viruses to E-beam irradiation was studied in whole
oysters and in oystermeat homogenates.Whole clutchless Eastern oysters
(Crassostrea virginica) were obtained from the Auburn University Aqua-
culture Facility in Dauphin Island, AL, or local Maryland distributors.
Oyster meat homogenates were prepared by blending the meat from
around 30 medium-sized oysters in a laboratory blender (model 31BL91;
Waring, New Hartford, CT) for 3 min at maximum speed. One-milliliter
aliquots of HAV (8.5 106 PFU/ml) andMNV (7.9 106 PFU/ml) were
mixed into the 10-ml oyster meat homogenate preparation. Live oysters
were permitted to accumulate HAV and MNV under simulated natural
conditions in an accumulation tank at the U.S. FDA Gulf Coast Seafood
Laboratory, Dauphin Island, AL, as described previously (13, 18). The
oysters were maintained for more than 3 weeks prior to being transferred
to a flume which utilized single-pass UV-treated natural seawater (with
salinity ranging between 5 to 20 ppt). To determine the sensitivity ofMNV
in the absence of an oyster matrix, MNV (7.9  106 PFU/ml) was also
suspended in 10 ml phosphate-buffered saline (PBS) and used in the ir-
radiation experiments. The oystermeat homogenates, the PBS-suspended
viruses, and the virus-spiked whole oysters were placed on blue ice and
shipped to Texas A&M University for the E-beam irradiation trials. The
samples were shipped in containers that met the International Air Trans-
port Association (IATA) Dangerous Goods Shipping Regulations (STP
100; SAF-T-PAK, Alberta, Canada).
Packaging samples for E-beam irradiation. In order to comply with
the university biosafety regulations, all virus-spiked samples were placed
in heat-sealed double-bagged Whirl Pak bags (Nasco, New York, NY).
These heat-sealed bags were then placed inside specimen transport bags
that were rated up to 95 kPa (Thermosafe, Arlington Heights, IL). Tripli-
cate packages of such sealed bags of virus-spiked PBS (10 ml) and oyster
homogenates (10 ml) were prepared. For whole oysters, similar heat-
sealed bags containing three virus-spiked whole oysters each were also
prepared for the E-beam irradiation trials.
E-beam irradiation and dosimetry. Experimental trials were per-
formed to ensure that the samples (live oysters, homogenate, or PBS)were
appropriately packaged and that they received uniform E-beam doses.
These dose-mapping trials included dose measurements with live oysters.
These trials were performed to ensure that the packages containing PBS,
oyster meat homogenate, or whole oysters could be irradiated effectively
with a dose uniformity ratio (DUR) of 1.0. The DUR is an important
criterion when performing irradiation experiments. A DUR of1.0 sig-
nifies that the dose is uniformwithin the package. Irradiation experiments
have to minimize dose variation within the experimental bags. Dose de-
livery trials were performed to determine the appropriate conveyor speed
and other specifications to achieve the target doses.
A 10-MeV E-beam linear accelerator was used for delivering E-beam
doses. Defined doses were delivered by conveying the samples across the
incident E-beam using commercial-scale computer processor-controlled
conveyor system. Dosimeters (L--alanine pellet dosimeters; Harwell
Dosimeters, Oxfordshire, United Kingdom) were placed at various posi-
tions on the packages to verify the delivered E-beam dose. As part of
dose-mapping experiments, dosimeters (in water-proof pouches) were
placed within the meat inside the oyster shell, except in cases where the
samples contained live viruses. The alanine dosimetry system that was
employed was traceable to international standards. The dosimeters were
measured using the Bruker E-scan spectrometer (Bruker, Billerica, MA)
to measure the delivered irradiation dose. Although the chosen target
doses were 0.5, 1.5, 3.5, 4.5, and 5.5 kGy, the actual measured doses were
used for data plotting and analysis. In order to determine the E-beamdose
required for complete inactivation of HAV and MNV, irradiation trials
were performed using higher doses, such as 5, 10, 20, and 30 kGy, with
oyster homogenate spiked with HAV (1.02  106 PFU/ml) and MNV
(4.07  106 PFU/ml). Nonirradiated samples (0 kGy) were used as con-
trols for both HAV and MNV. The irradiated as well as nonirradiated
samples were shipped under blue-ice conditions overnight back to the
USDA-ARS laboratory in Dover, DE, for virus extraction and assays. The
irradiation of samples and shipment to the USDA-ARS laboratory were
completed within 24 h of receiving the samples for irradiation.
Virus extraction and enumeration. Three whole irradiated virus-
contaminated oysters from the sample bags were shucked, and the con-
tents of the oysters were pooled and placed in 50-ml conical tubes. The
tubes were briefly centrifuged in a tabletop centrifuge to facilitate separa-
tion of oyster meat from oyster liquor. Virus extractions were performed
as described by Calci et al. (18). Briefly, the oyster meat was placed in 200
ml of phosphate buffer (0.15MNa3PO4, pH 9.5) and homogenized using
a laboratory blender (Waring Inc., New Hartford, CT) for 3 min at the
maximum speed setting. The homogenates were pelleted for 15 min at
15,000  g, and the supernatant was retained and neutralized with 2N
HCl. Tenfold serial dilutions of neutralized supernatant were made in
Earle’s balanced salt solution (EBSS) (Gibco-Invitrogen, Grand Island,
NY). For oyster homogenates, 10 ml was mixed with 25 ml of phosphate
buffer, followed by centrifugation, neutralization of the supernatant, and
dilution in EBSS as described above.
HAV assays were performed using 2 ml of extract or 2 ml of 10-fold
serial dilutions made in EBSS. Plaque assays were performed in triplicate
using FRhK-4 cells as described by Richards andWatson (14). For MNV,
plaque assays were performed in triplicate using confluent monolayers of
RAW cells (19). The MNV plaque assay was essentially as described by
Kingsley et al. (13), assaying 0.5 ml of extract or 0.5 ml of 10-fold serial
dilutions. Due to oyster debris in the oyster homogenates, the plates were
washed with 2 ml of EBSS after inoculation and incubation for 2 h. For
homogenate dilutions of 1:100 or greater, 0.5 ml was used to infect indi-
vidual wells of a 6-well dish and the washing step was omitted. The virus
plaque assays were recorded as PFU per ml. In the case of MNV in PBS,
samples were directly diluted in EBSS and used for plaque assay.
Quantitative microbial risk assessment. We estimated the infection
risks that would arise from exposure to HAV-contaminated oysters and
human norovirus-contaminated oysters. For these risk calculations, we
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assumed that the inactivation of human norovirus under E-beam irradi-
ation was equal to that of MNV. The reductions of MNVwere used as the
basis for calculating the reduction of risks associated with human norovi-
ruses. A standard U.S. serving size of 12 oysters, with each oyster contain-
ing approximately 13.68 g of oystermeat, was assumed (20). Reduction in
infection risks associated with various levels of virus contamination loads
and various doses of E-beam irradiation were estimated. Additionally, the
infection risks associated with smaller serving sizes of only 6 and 3 oysters
were calculated to determine whether infection risks could be reduced by
a combination of E-beam processing and smaller serving sizes. The initial
HAVandNoVvirus loadswere assumed to be 1, 10, 100, and 1,000 PFU/g.
The infection risks were estimated using the beta-Poissonmodel,Pi 1
(1N/), where Pi is the probability of infection andN is the number
of viruses ingested.  and  are parameters reflecting the dose-response
curve for NoV and HAV. For NoV,  (0.04) and  (0.055) were based on
the dose-response curve for human norovirus (21). For HAV,  (0.374)
and (186.69) were based on the dose-response curve published by Pinto
et al. (22). We assumed that all viruses in the oysters were infectious and
that all of the exposed individuals were susceptible to infection.
Data analysis. ForMNV, three independent E-beam irradiation trials
(with three replicates each) were performed for the whole-oyster and oys-
ter homogenate samples, and two independent irradiation trials were
done for PBS samples. In the case of HAV, two independent trials (with
three replicates each) for whole oysters and oyster homogenates were
performed. In order to determine complete inactivation of viruses by
higher E-beam dose, three separate irradiation trials (with three replicates
each) were conducted for oyster homogenate spiked with HAV. In the
case of oyster homogenate spiked with MNV, two independent irradia-
tion trials (with three replicates each)were conductedwith higher doses of
E-beam. The inactivation of the viruses by E-beam irradiation was as-
sumed to be linear (23). The D10 value represents the dose that achieves a
90% (1-log) reduction of the target virus. The surviving HAV and MNV
concentrations (log PFU/ml) were plotted as a function of the measured
E-beam dose (kGy). Linear regression analysis was performed, and the
negative reciprocal of the slope was calculated to be the D10 value. The
Student’s t test was performed to determine whether there was any statis-
tically significant difference between the D10 values of the two viruses in
the different matrices.
RESULTS
Inactivation of MNV in oyster homogenate and whole oysters.
To evaluate MNV inactivation by E-beam, oyster homogenates
were seeded withMNV and live oysters were contaminated under
simulated natural bioaccumulation by placing them in MNV-
contaminated seawater. The reduction of human norovirus sur-
rogate, MNV spiked in PBS, oyster homogenate, and whole oys-
ters when exposed to various doses of E-beam irradiation is shown
in Fig. 1. The inactivation of MNV in PBS was greater than that in
oyster homogenate and whole oysters. The dose required for
achieving 90% reduction (D10 value) for MNV in PBS, oyster ho-
mogenate, and whole oysters was calculated to be 2.55 ( 0.42),
4.97 ( 0.65), and 4.05 ( 0.63) kGy, respectively (Table 1). The
inactivation of MNV was significantly greater in PBS than in
whole oysters (P 0.0373) or the oyster meat homogenate (P	
0.0001). There was no statistically significant difference in MNV
inactivation irrespective of whether the virus was present in the
oyster homogenate or in whole oysters. At the maximum deliv-
ered dose of 5.45 kGy, MNV was reduced by approximately 90%
in whole oysters.
Inactivation of HAV in oyster homogenate and whole oys-
ters. Figure 2 shows the inactivation of HAV in oyster homoge-
nate and whole oysters when exposed to various doses of E-beam
irradiation. E-beam irradiation inactivates the virus in whole oys-
ters as well as in the oyster homogenate. However, the dose re-
quired for achieving a 90% reduction (D10 value) of HAV in the
oyster homogenate andwhole oysters was calculated to be 5.74 (
0.86) kGy in the homogenate and 4.83 ( 0.08) kGy in whole
oysters (Table 1). There was no significant difference (P 0.142)
between the D10 values of HAV in the oyster homogenate and that
in whole oysters (Table 1). At themaximumdose (5.5 kGy) that
was applied, approximately 94% of the original virus titer was
inactivated within whole oysters.
Table 2 shows the results from the experiments conducted
to determine the E-beam dose required for complete inactiva-
tion of viruses in the oyster meat matrix. Separate oyster meat
homogenates were spiked with MNV and HAV and subjected
to higher E-beam doses. A dose of23 kGy resulted in 4.2- and
4.5-log reductions of MNV and HAV, respectively. Delivery of
0.0
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FIG 1 Inactivation of murine norovirus (MNV-1) under various 10-MeV
E-beam doses when present in whole oysters, oyster homogenate, and phos-
phate-buffered saline. The apparent filled squares are those data points where
the open squares overlap the solid circles.
TABLE 1 D10 values for MNV-1 and hepatitis A virus in PBS, oyster
meat homogenate, and whole oysters when exposed to 10-MeV E-beam
irradiation
Matrix
D10 value
a (kGy)
MNV-1 HAV (VR-1402)
Phosphate-buffered saline 2.55 0.42A ND
Oyster homogenate 4.97 0.65B 5.74 0.86B
Whole oysters 4.05 0.63B 4.83 0.03B
a Values are means standard deviations. D10 values with different letters indicate
statistically significant (P 0.05) differences. ND, not determined.
) -0.5
0.0
HAV-Oyster homogenate
HAV- Whole Oyster
Lo
g(
N
/N
0)
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0 2 4 6
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E-beam dose (kGy)
FIG 2 Inactivation of hepatitis A virus (ATCC VR-1422) under various 10
MeV E-beam doses when present in whole oysters and in oyster homogenate.
The apparent filled squares are those data points where the open squares over-
lap the solid circles.
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a higher dose of 32 kGy reduced viruses to below detectable
levels (Table 2).
Reduction in infection risks achievable with E-beam irradia-
tion. Table 3 represents the reductions in HAV-associated infec-
tion risks if E-beam irradiation is employed on whole oysters con-
taminated at various virus levels (102, 103, 104, and 105 PFU). As
stated earlier, an average serving size of 12 oysters with 13.68 g of
meat/oyster was used in these calculations (20). At various doses
of E-beam irradiation, ranging from approximately 1.5 to 5.5 kGy,
there is a corresponding reduction in infection risks. If a serving
size (12 oysters at 13.68 g meat/oyster) had a total contamination
level of 105 PFU, 9.21 out of 10 susceptible persons would become
ill if the oysters were not treated with E-beam irradiation. If these
oysters were E-beam irradiated at 5.5 kGy, the infection risks
would be reduced by approximately 16% (from 9.21  101 to
7.76  101). If the oysters had an initial contamination level of
approximately 104 PFU, the use of 5.5 kGy of E-beam irradiation
would reduce the risk by approximately 39% (from8.13 101 to
4.99  101). If the initial virus contamination in oysters is lim-
ited to 103 PFU, employing an E-beam dose of 5.5 kGy would
theoretically achieve a health risk reduction of 74% (from 5.74
101 to 1.48 101). At themaximumFDA-approved dose of 5.5
kGy and a total virus load of 102 PFU in a serving, the reduction of
HAV would be approximately 91% (from 2.10 101 to 1.93
102) (Table 3). The only logarithmic reduction of infection risk
occurs when the oysters harbor viruses at low levels ( 102 PFU)
and the oysters are exposed to doses of2.5 kGy (Table 3).
Based on the assumption that MNV and NoV have similar
sensitivities to E-beam treatments, Table 4 shows the reduction of
infection risks that can be expected when NoV-contaminated
whole oysters are treated with E-beam irradiation. At the maxi-
mumdose (5.0 kGy) that was tested, theMNV titers were reduced
by about 90% (Table 4). However, there was no significant (i.e.,
logarithmic) reduction of potential NoV infection risks at any of
the E-beam doses. The infection risks are reduced by approxi-
mately 12%, from 4.49 101 to 3.95 101 (if the initial virus
titer per serving size was 105 PFU) and by approximately 26%
(from 2.74  101 to 2.03  101) if the initial virus titer per
serving size was 102 PFU. We modeled the influence of reduced
oyster serving size to further evaluate the effect E-beam irradiation
would have on potential public health risks (Table 5). Using hy-
pothetical serving sizes of 3 and 6 whole oysters in these calcula-
tions, it was evident that even with a reduced serving size, there
would be no significant reduction (i.e., log reduction) in human
norovirus infection risks (Table 5).
DISCUSSION
The focus of this study was to understand the inactivation kinetics
of HAV and MNV-1 under E-beam irradiation and its potential
application as a viral pathogen intervention technology for oys-
ters. Since assessment of inactivation of human norovirus is not
currently feasible without the use of human subjects, MNV-1 was
used as an NoV surrogate (13, 24). A key secondary objective of
TABLE 2 Inactivation of MNV-1 and hepatitis A virus (VR-1402) in
oyster meat homogenate exposed to various high doses of 10-MeV E-
beam irradiation
Inactivation of:
MNV-1 HAV (VR-1402)
E-beam dose (kGy) Log PFU/mla E-beam dose (kGy) Log PFU/mlb
0.00 4.898 0.00 4.26
4.90 3.570 4.85 3.39
9.38 2.362 10.06 2.31
23.64 0.362 23.20 0.04
31.90 BD 32.17 BD
a Values refers to mean log PFU/ml from 6 replicates. BD, below detection limit of
plaque assay for MNV-1 (23 PFU/ml) and HAV (6 PFU/ml).
b Values refers to mean log PFU/ml from 9 replicate trials.
TABLE 3 Possible infection risks associated with hepatitis A virus-
contaminated oysters after treatment with various E-beam doses
E-beam dosea (kGy)
(% HAV reduction)
Infection riskb for consuming oystersc with various
levels of HAV contamination
105 PFU 104 PFU 103 PFU 102 PFU
0 (0) 9.21 101 8.13 101 5.74 101 2.10 101
0.8 (44.5) 9.01 101 7.68 101 4.85 101 1.38 101
1.55 (55.1) 8.93 101 7.50 101 4.50 101 1.17 101
2.49 (76.4) 8.64 101 6.84 101 3.43 101 6.81 102
3.50 (87.3) 8.29 101 6.08 101 2.45 101 3.89 102
4.34 (86.9) 8.31 101 6.11 101 2.49 101 3.99 102
5.54 (93.9) 7.76 101 4.99 101 1.48 101 1.93 102
a Virus reduction at specified E-beam doses.
b Probability of infection.
c Serving size of 12 oysters containing 13.68 g meat per oyster.
TABLE 4 Possible infection risks associated with human norovirus-
contaminated oysters after treatment with various E-beam doses
E-beam dosea (kGy)
(% MNV reduction)
Infection riskb for consuming oystersc with various
levels of NoV contamination
105 PFU 104 PFU 103 PFU 102 PFU
0 (0) 4.49 101 3.96 101 3.38 101 2.74 101
1.44 (46.8) 4.35 101 3.81 101 3.21 101 2.55 101
2.31 (78.5) 4.14 101 3.58 101 2.96 101 2.28 101
3.23 (89.7) 3.97 101 3.39 101 2.75 101 2.05 101
4.13 (91.3) 3.93 101 3.34 101 2.70 101 1.99 101
5.09 (90.4) 3.95 101 3.37 101 2.73 101 2.03 101
a Virus reduction at specified E-beam doses.
b Probability of infection.
c Serving size of 12 oysters containing 13.68 g meat per oyster.
TABLE 5 Comparison of infection risks associated with consuming
human norovirus-contaminated whole oysters of various serving sizes
with and without E-beam irradiation
E-beam dose and
serving size
(no. of oysters)
Infection riska for consuming oysters with various
levels of NoV contamination
105 PFU 104 PFU 103 PFU 102 PFU
No irradiation
12 4.49 101 3.96 101 3.38 101 2.74 101
6 4.34 101 3.79 101 3.19 101 2.53 101
3 4.18 101 3.62 101 3.00 101 2.33 101
5.09 kGy (90.4% NoV
reduction)
12 3.95 101 3.37 101 2.73 101 2.03 101
6 3.78 101 3.18 101 2.52 101 1.80 101
3 3.61 101 2.99 101 2.31 101 1.58 101
a Probability of infection.
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this study was to determine the reduction in potential public
health risks that could be realized with viral inactivation under
E-beam irradiation conditions. Tomake this study relevant to the
commercial oyster industry and to public health needs, E-beam
treatments up to the currently approved maximum FDA-allow-
able doses were employed for both whole oysters and oyster ho-
mogenate. However, to determine the dose required for complete
inactivation of the viruses in the oystermeat, higher E-beamdoses
were utilized.
Gamma radiation as a sanitization treatment for shellfish has
been studied by different research groups (12, 16, 25–28). A vari-
ety of bacterial pathogens are susceptible to ionizing radiation,
such as Vibrio cholerae, V. parahaemolyticus, and V. vulnificus,
with D10 values as low as 0.1 kGy (27, 29). Inactivation studies on
Salmonella spp. with live oysters showed a relatively low D10 value
of 0.45 to 0.55 kGy (16). Harewood et al. (12) reported that virus
inactivation required a higher dose of irradiation than bacterial
pathogens. A D10 value of 13.5 kGy was reported for F coliphages
(12). Mallet et al. (27), when employing gamma irradiation, re-
ported no significant difference in the inactivation of viral patho-
gens, reporting D10 values of 2.02, 3.1, and 2.4 kGy for HAV,
poliovirus I, and rotavirus SA11, respectively. As stated earlier, we
are not aware of any published studies on enteric viruses in whole
oysters treated with E-beam irradiation.
This study demonstrates that E-beam irradiation is capable of
inactivating HAV and MNV in whole oysters (Fig. 1 and 2 and
Table 2). However, at the FDA-approved maximum dose of 5.5
kGy, the reduction of HAV and MNV in whole oysters does not
exceed 94 and 90%, respectively. The matrix in which the virus is
present does have an impact on MNV sensitivity to E-beam irra-
diation. The D10 value of MNVwas significantly lower (P	 0.05)
when present in PBS than when present in oyster meat homoge-
nate or whole oysters (Table 1). This indicates that the oystermeat
reduces the effectiveness of E-beam irradiation. A keymechanism
of microbial inactivation by ionizing radiation involves reactive
oxygen species which damage the nucleic acids (17). The presence
of organic materials in the irradiation matrix is known to reduce
irradiation effectiveness, as they scavenge the reactive species pro-
duced during treatment (30, 31). Reduction of water activity,
which lowers the radiolytic splitting of water molecules, has also
been reported to be responsible for attenuation of radiation effects
(28). We do not know whether MNV or HAV accumulate in he-
mocytes, similar to humanNoV, which is known to accumulate in
hemocytes. The location of the enteric viruses within the oyster’s
tissue could have an influence on their sensitivity to ionizing ra-
diation if it is protected from the reactive oxygen species. It has
been reported that MNV shows differential inactivation depend-
ing onwhether it is present on cabbage or strawberries (32). How-
ever, using poliovirus and rotavirus, we have recently shown that
while there are inactivation differences on fresh produce, such as
lettuce and spinach, these observed differences were not statisti-
cally significant (23). This suggests that factors other than matrix
play a role in the inactivation of viruses during ionizing irradia-
tion.
Assuming that the response observed with MNV-1 to E-beam
is the best-case scenario of how NoV will respond to E-beam irra-
diation, these results suggest that virus infection risks arising from
shellfish cannot be eliminated with E-beam processing at the cur-
rent U.S. FDA-approved level of 5.5 kGy. The combined inherent
resistance of enteric viruses to ionizing irradiation and the highly
infectious nature of NoV indicate that E-beam would only be
effective if the oysters had low initial levels of virus contamination
(Table 4). The actual level of virus contamination required for
oyster-borne virus transmission is unclear. Doré et al. (33) excised
and tested oyster digestive tissue and found that oysters associated
with NoV outbreaks contained 1,000 NoV genomic units/g.
Also, Lowther et al. (34) and Le Guyader et al. (35) have reported
two large outbreaks that were associated with NoV levels of

8,000 viral genome copies per g digestive tissue. Using human
volunteers, Leon et al. (36) have shown that a total dose (injected
into oysters) of 1 104 genome equivalent copies was capable of
eliciting norovirus infection.
Overall, these studies show that the use of the U.S. FDA-ap-
proved E-beam at 5.5 kGy does inactivate MNV and HAV by
greater than 90% in shellfish. However, the potential health risks
associated with this reduced virus load still is not significantly
different from the health risks associated with consuming unirra-
diated oysters. If E-beam irradiation (at the maximum FDA ap-
proved dose) is used, the NoV infection risks will be reduced by
about 12% (from 4.49  101 to 3.95  101) if the virus con-
tamination in oysters was 105 PFU. However, if the average serv-
ing size of oysters contained approximately 104 or 103 PFU, the
reduction in NoV infection risks will be approximately 15%
(3.96  101 to 33.7  101) and 19% (from 3.38  101 to
2.73 101), respectively. It must, however, be emphasized that
these predictions are based onmurine norovirus, an experimental
surrogate of human norovirus. At very low NoV contamination
levels (102 PFU), there will be a 26% reduction (from 2.74 
101 to 2.03 101) in infection risks.
In the case of HAV, however, the use of E-beam processing
could result in reduction of health risks. Assuming that the aver-
age serving size of oysters harbored a total of approximately 105
PFU of HAV, the use of E-beam irradiation would achieve a 16%
reduction (from 9.21 101 to 7.76 101) of infection risks. At
lower levels of contamination (102 PFU), the reduction in infec-
tion risks is estimated to be 91% (from 2.10  101 to 1.93 
102) (Table 3). Calci et al. (18) reported that oysters in natural
estuarine waters can concentrate HAV to quite high levels (
105)
in a relatively short period of time (24 h). Thus, for HAV, 5.5-kGy
treatment does result in 1 log reduction in infection risk but
only at relatively low virus contamination levels. In fact, the po-
tential HAV risk would reduce from 20 to 2% (from 2 in 10 per-
sons to 2 in 100 persons) (Table 3) if a typical serving size of
oysters contained approximately 102 PFU.
In conclusion, this study shows that both HAV and MNV are
susceptible to E-beam irradiation. However, at FDA-approved
doses, the reduction of HAV and MNV-1 in shellfish is limited to
only around 90%. While E-beam irradiation does not completely
eliminate shellfish-associated virus infection risks, some benefits
can be expected. In 1995, the FDA estimated that shellfish-associ-
ated illnesses (bacterial and viral) cost the U.S. economy approx-
imately $200 million (37). It is important to calculate the cost
savings that could be realized with the reduction in virus-related
health risks that were identified in this study. Given the large eco-
nomic costs associatedwith norovirus infections, these reductions
in infection risks with the use of E-beam irradiation technology
could yield significant cost savings for countries such as the
United States. It needs to be emphasized that a pathogen-kill step,
such as E-beamprocessing, ismeant to be part of a comprehensive
HACCP plan that includes classification of growing areas and
Praveen et al.
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monitoring of fecal coliforms andmanagement strategies, such as
closure during high-rainfall events. Lastly, this study shows that
current commercial irradiation of shellfish to address Vibrio spp.
contamination can have collateral reduction of virus levels, albeit
modest. This study also emphasizes the need to develop new tech-
nologies that could be used in conjunction with E-beam irradia-
tion to significantly reduce virus health risks. The sensory attri-
butes of E-beam-processed oysters were not part of this study but
warrant further studies.
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